Radnor Capital Management LLC Cuts Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Radnor Capital Management LLC lessened its holdings in Cardinal Health, Inc. (NYSE:CAH) by 12.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,109 shares of the company’s stock after selling 300 shares during the quarter. Radnor Capital Management LLC’s holdings in Cardinal Health were worth $249,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of Cardinal Health by 21.6% during the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 821 shares of the company’s stock worth $97,000 after purchasing an additional 146 shares in the last quarter. Park Avenue Securities LLC boosted its holdings in Cardinal Health by 17.5% during the fourth quarter. Park Avenue Securities LLC now owns 24,426 shares of the company’s stock worth $2,889,000 after buying an additional 3,643 shares in the last quarter. Kathmere Capital Management LLC grew its position in Cardinal Health by 4.7% during the fourth quarter. Kathmere Capital Management LLC now owns 4,068 shares of the company’s stock worth $481,000 after buying an additional 182 shares during the period. Accurate Wealth Management LLC purchased a new position in Cardinal Health in the fourth quarter valued at about $222,000. Finally, FNY Investment Advisers LLC acquired a new stake in shares of Cardinal Health during the 4th quarter valued at approximately $94,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of CAH opened at $127.03 on Friday. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $127.08. The company has a market capitalization of $30.74 billion, a PE ratio of 24.71, a price-to-earnings-growth ratio of 1.48 and a beta of 0.63. The stock has a fifty day moving average of $120.46 and a two-hundred day moving average of $111.50.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same period in the prior year, the firm posted $1.73 earnings per share. The business’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.82 earnings per share for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd were given a $0.5056 dividend. The ex-dividend date was Thursday, January 2nd. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s dividend payout ratio is presently 39.30%.

Analysts Set New Price Targets

CAH has been the topic of a number of research reports. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $132.00 to $145.00 in a report on Monday, January 6th. UBS Group raised their price target on Cardinal Health from $134.00 to $139.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Barclays boosted their price objective on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a research report on Monday, November 4th. Wells Fargo & Company upgraded shares of Cardinal Health from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $101.00 to $127.00 in a report on Friday, December 13th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a report on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.